UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

The Lancet infectious diseases, 2017-08, Vol.17 (8), p.854-866

2017

Volltextzugriff (PDF)

Dengue: The Risk to Developed and Developing Countries

Proceedings of the National Academy of Sciences - PNAS, 1994-03, Vol.91 (7), p.2395-2400

Monath, Thomas P.

1994

Volltextzugriff (PDF)

Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates

Journal of Virology, 2004-05, Vol.78 (9), p.4761-4775

2004

Volltextzugriff (PDF)

Challenge model for Helicobacter pylori infection in human volunteers

Gut, 2004-09, Vol.53 (9), p.1235-1243

2004

Volltextzugriff (PDF)

Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine

Journal of Virology, 2001-08, Vol.75 (16), p.7290-7304

2001

Volltextzugriff (PDF)

Japanese encephalitis vaccines: current vaccines and future prospects

Current topics in microbiology and immunology, 2002, Vol.267, p.105

Monath, T P

2002

Volltextzugriff (PDF)

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax™) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates

Vaccine, 1999-04, Vol.17 (15), p.1869-1882

1999

Volltextzugriff (PDF)

Recombinant Chimeric Yellow Fever-Dengue Type 2 Virus Is Immunogenic and Protective in Nonhuman Primates

Journal of Virology, 2000-06, Vol.74 (12), p.5477-5485

2000

Volltextzugriff (PDF)

Viremia and Immunogenicity in Nonhuman Primates of a Tetravalent Yellow Fever–Dengue Chimeric Vaccine: Genetic Reconstructions, Dose Adjustment, and Antibody Responses against Wild-type Dengue Virus Isolates

Virology (New York, N.Y.), 2002-06, Vol.298 (1), p.146-159

2002

Volltextzugriff (PDF)

Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers

Gut, 2002-11, Vol.51 (5), p.634-640

2002

Volltextzugriff (PDF)

Yellow fever as an endemic/epidemic disease and priorities for vaccination

Bulletin de la Societe de pathologie exotique (1990), 2006-12, Vol.99 (5), p.341-347

MONATH, T. P

2006

Volltextzugriff (PDF)

Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori–infected adults

Gastroenterology (New York, N.Y. 1943), 1999-04, Vol.116 (4), p.804-812

1999

Volltextzugriff (PDF)

Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax-JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen

The Journal of infectious diseases, 2003-10, Vol.188 (8), p.1213-1230

2003

Volltextzugriff (PDF)

Molecular Basis for Attenuation of Neurovirulence of a Yellow Fever Virus/Japanese Encephalitis Virus Chimera Vaccine (ChimeriVax-JE)

Journal of Virology, 2001-01, Vol.75 (2), p.934-942

2001

Volltextzugriff (PDF)

A Single Amino Acid Substitution in the Envelope Protein of Chimeric Yellow Fever-Dengue 1 Vaccine Virus Reduces Neurovirulence for Suckling Mice and Viremia/Viscerotropism for Monkeys

Journal of Virology, 2004-09, Vol.78 (18), p.9998-10008

2004

Volltextzugriff (PDF)

Prospects for Development of a Vaccine against the West Nile Virus

Annals of the New York Academy of Sciences, 2001-12, Vol.951 (1), p.1-12

MONATH, THOMAS P.

2001

Volltextzugriff (PDF)

Prevention of Yellow Fever in Persons Traveling to the Tropics

Clinical infectious diseases, 2002-05, Vol.34 (10), p.1369-1378

2002

Volltextzugriff (PDF)

Chimeric Yellow Fever Virus 17D-Japanese Encephalitis Virus Vaccine: Dose-Response Effectiveness and Extended Safety Testing in Rhesus Monkeys

Journal of Virology, 2000-02, Vol.74 (4), p.1742-1751

2000

Volltextzugriff (PDF)

Immunogenicity, Genetic Stability, and Protective Efficacy of a Recombinant, Chimeric Yellow Fever-Japanese Encephalitis Virus (ChimeriVax-JE) as a Live, Attenuated Vaccine Candidate against Japanese Encephalitis

Virology (New York, N.Y.), 1999-05, Vol.257 (2), p.363-372

1999

Volltextzugriff (PDF)

Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults

Infection and immunity, 2001-02, Vol.69 (2), p.988-995

2001

Volltextzugriff (PDF)

Vaccines against diseases transmitted from animals to humans: A one health paradigm

Vaccine, 2013-11, Vol.31 (46), p.5321-5338

Monath, Thomas P

2013

Volltextzugriff (PDF)

Pathogenesis and Pathophysiology of Yellow Fever

Advances in Virus Research, 2003, Vol.60, p.343-395

2003

Volltextzugriff (PDF)

Intranasal Antibody Prophylaxis for Protection against Viral Disease

Clinical Microbiology Reviews, 1999-07, Vol.12 (3), p.383-393

1999

Volltextzugriff (PDF)

Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis

The Journal of infectious diseases, 1995-07, Vol.172 (1), p.161-172

1995

Volltextzugriff (PDF)

Specific Immunoglobulin A Antibodies in Maternal Milk and Delayed Helicobacter pylori Colonization in Gambian Infants

Clinical infectious diseases, 2004-10, Vol.39 (8), p.1155-1160

2004

Volltextzugriff (PDF)

1 – 25 von 576

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(480)
Mit Volltextzugriff
(386)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(553)
Französisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(341)
Life Sciences & Biomedicine
(318)
Humans
(250)
Animals
(229)
Infectious Diseases
(147)
Biological And Medical Sciences
(141)
Female
(121)
Microbiology
(111)
Immunology
(109)
Medical Sciences
(99)
Virology
(99)
Tropical Medicine
(87)
Male
(83)
Fundamental And Applied Biological Sciences. Psychology
(79)
Adult
(75)
Mice
(74)
Viral Diseases
(74)
Public, Environmental & Occupational Health
(70)
Vaccines
(67)
Human Viral Diseases
(65)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

Dengue: The Risk to Developed and Developing Countries

Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates

Challenge model for Helicobacter pylori infection in human volunteers

Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine

Japanese encephalitis vaccines: current vaccines and future prospects

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax™) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates

Recombinant Chimeric Yellow Fever-Dengue Type 2 Virus Is Immunogenic and Protective in Nonhuman Primates

Viremia and Immunogenicity in Nonhuman Primates of a Tetravalent Yellow Fever–Dengue Chimeric Vaccine: Genetic Reconstructions, Dose Adjustment, and Antibody Responses against Wild-type Dengue Virus Isolates

Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers

Yellow fever as an endemic/epidemic disease and priorities for vaccination

Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori–infected adults

Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax-JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen

Molecular Basis for Attenuation of Neurovirulence of a Yellow Fever Virus/Japanese Encephalitis Virus Chimera Vaccine (ChimeriVax-JE)

A Single Amino Acid Substitution in the Envelope Protein of Chimeric Yellow Fever-Dengue 1 Vaccine Virus Reduces Neurovirulence for Suckling Mice and Viremia/Viscerotropism for Monkeys

Prospects for Development of a Vaccine against the West Nile Virus

Prevention of Yellow Fever in Persons Traveling to the Tropics

Chimeric Yellow Fever Virus 17D-Japanese Encephalitis Virus Vaccine: Dose-Response Effectiveness and Extended Safety Testing in Rhesus Monkeys

Immunogenicity, Genetic Stability, and Protective Efficacy of a Recombinant, Chimeric Yellow Fever-Japanese Encephalitis Virus (ChimeriVax-JE) as a Live, Attenuated Vaccine Candidate against Japanese Encephalitis

Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults

Vaccines against diseases transmitted from animals to humans: A one health paradigm

Pathogenesis and Pathophysiology of Yellow Fever

Intranasal Antibody Prophylaxis for Protection against Viral Disease

Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis

Specific Immunoglobulin A Antibodies in Maternal Milk and Delayed Helicobacter pylori Colonization in Gambian Infants

Suchergebnisse filtern